Cargando…
Glycated hemoglobin variability: A potential new risk marker for diabetes complications?
Autor principal: | Jia, Weiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234224/ https://www.ncbi.nlm.nih.gov/pubmed/25422761 http://dx.doi.org/10.1111/jdi.12227 |
Ejemplares similares
-
Glycated hemoglobin variability and retinopathy progression in type 1 diabetes: Is month‐to‐moth instability a better predictor?
por: Chang, Chia‐Hsuin, et al.
Publicado: (2013) -
International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values
por: Kashiwagi, Atsunori, et al.
Publicado: (2012) -
Glycated albumin is correlated with glycated hemoglobin in type 2 diabetes
por: Ciobanu, Dana Mihaela, et al.
Publicado: (2019) -
Cognitive decline in elderly patients with type 2 diabetes is associated with glycated albumin, ratio of Glycated Albumin to glycated hemoglobin, and concentrations of inflammatory and oxidative stress markers
por: Si, Si-Cong, et al.
Publicado: (2023) -
Glycated hemoglobin HbA(1c) – a new risk marker for the outcome of cardiac surgery?
por: Biskupski, Andrzej, et al.
Publicado: (2014)